VLA15

1 articles
Lyme Disease Vaccine Candidate VLA15 Advances Through Phase 1 Trials
Jul 16, 2018 | Emily Wolfson

  Valneva, a French biotech company focused on developing vaccines, has announced it has obtained successful Phase 1 results for its Lyme disease...